Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 2
2008 5
2009 3
2010 7
2011 10
2012 8
2013 2
2014 8
2015 8
2016 4
2017 6
2018 6
2019 4
2020 2
2021 2
2022 1
2023 4
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

75 results

Results by year

Filters applied: . Clear all
Page 1
First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer.
Horn L, Mansfield AS, Szczęsna A, Havel L, Krzakowski M, Hochmair MJ, Huemer F, Losonczy G, Johnson ML, Nishio M, Reck M, Mok T, Lam S, Shames DS, Liu J, Ding B, Lopez-Chavez A, Kabbinavar F, Lin W, Sandler A, Liu SV; IMpower133 Study Group. Horn L, et al. N Engl J Med. 2018 Dec 6;379(23):2220-2229. doi: 10.1056/NEJMoa1809064. Epub 2018 Sep 25. N Engl J Med. 2018. PMID: 30280641 Clinical Trial.
Crizotinib.
Heigener DF, Reck M. Heigener DF, et al. Recent Results Cancer Res. 2018;211:57-65. doi: 10.1007/978-3-319-91442-8_4. Recent Results Cancer Res. 2018. PMID: 30069759 Review.
Crizotinib.
Heigener DF, Reck M. Heigener DF, et al. Recent Results Cancer Res. 2014;201:197-205. doi: 10.1007/978-3-642-54490-3_11. Recent Results Cancer Res. 2014. PMID: 24756793 Review.
[Palliative aspects in pulmonary oncology].
Heigener D, Delis S. Heigener D, et al. Pneumologie. 2024 May;78(5):325-329. doi: 10.1055/a-2206-5602. Epub 2023 Dec 11. Pneumologie. 2024. PMID: 38081220 Review. German.
Targeting of MEK in lung cancer therapeutics.
Heigener DF, Gandara DR, Reck M. Heigener DF, et al. Lancet Respir Med. 2015 Apr;3(4):319-27. doi: 10.1016/S2213-2600(15)00026-0. Epub 2015 Mar 20. Lancet Respir Med. 2015. PMID: 25801412 Review.
Palliative care concepts in respiratory disease.
Heigener DF, Rabe KF. Heigener DF, et al. Respiration. 2011;82(6):483-91. doi: 10.1159/000334189. Epub 2011 Nov 22. Respiration. 2011. PMID: 22116516 Free article. Review.
Immune checkpoint blockade in small cell lung cancer.
Tay RY, Heigener D, Reck M, Califano R. Tay RY, et al. Among authors: heigener d. Lung Cancer. 2019 Nov;137:31-37. doi: 10.1016/j.lungcan.2019.08.024. Epub 2019 Aug 22. Lung Cancer. 2019. PMID: 31525648 Review.
Lung cancer in 2017: Giant steps and stumbling blocks.
Heigener DF, Reck M. Heigener DF, et al. Nat Rev Clin Oncol. 2018 Feb;15(2):71-72. doi: 10.1038/nrclinonc.2017.178. Epub 2017 Nov 21. Nat Rev Clin Oncol. 2018. PMID: 29158589 Review. No abstract available.
75 results